IP Library › Granted Patent US 7,385,023
Granted Patent B1
US 7,385,023 · App. 10/130,413 · Granted Jun 10, 2008

Cancer immunotherapy and diagnosis using cytochrome P450 1B1

Assignees: Trustees of Boston University; Dana Farber Cancer Institute, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,385,023
App. No.
10/130,413
Granted
Jun 10, 2008
Kind
B1
Abstract

The invention provides methods for conducting cancer immunotherapy and diagnosis using cytochrome P450 1B1 and peptide fragments thereof.

Claims (1)

1. A purified cytochrome P450 1B1 peptide that binds to a major histocompatibility complex molecule, wherein said peptide consists of CYP190 (SEQ ID NO:3).

Assignments (3)
CONFIRMATORY LICENSE Recorded Oct 19, 2016
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040417/0489 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2002
From: SHERR, DAVID
To: TRUSTEES OF BOSTON UNIVERSITY, A MASSACHUSETTS CORPORATION
Reel/Frame 013564/0937 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2002
From: SCHULTZE, JOACHIM L.; VONDERHEIDE, ROBERT H.; NADLER, LEE M.; MAECKER, BRITTA; BERGWELT-BAILDON, MICHAEL
To: DANA FARBER CANCER INSTITUTE, INC.
Reel/Frame 013565/0067 →
Continuity (1)
Provisional Application 6016559000 · Nov 15, 2000